Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 25798 | 272 | 41.5 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
| 2612 | 2 | WARBURG EFFECT//PKM2//PYRUVATE KINASE | 3575 |
| 25798 | 1 | 2 DEOXY D GLUCOSE//CELL BIOL R 124//METABOLIC OXIDATIVE STRESS | 272 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 2 DEOXY D GLUCOSE | authKW | 802093 | 19% | 14% | 51 |
| 2 | CELL BIOL R 124 | address | 336786 | 1% | 100% | 3 |
| 3 | METABOLIC OXIDATIVE STRESS | authKW | 144334 | 1% | 43% | 3 |
| 4 | 6 AMINONICOTINAMIDE | authKW | 127915 | 3% | 16% | 7 |
| 5 | 2 DEM D GLUCOSE | authKW | 112262 | 0% | 100% | 1 |
| 6 | 2 DEOXY D GLUCOSE P53 | authKW | 112262 | 0% | 100% | 1 |
| 7 | 2 METHOXY ANTIMYCIN A | authKW | 112262 | 0% | 100% | 1 |
| 8 | ADV PROTEOMICS | address | 112262 | 0% | 100% | 1 |
| 9 | BAX BAK INDEPENDENT | authKW | 112262 | 0% | 100% | 1 |
| 10 | CAMPTODIECIN | authKW | 112262 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 2432 | 49% | 0% | 133 |
| 2 | Radiology, Nuclear Medicine & Medical Imaging | 382 | 15% | 0% | 42 |
| 3 | Biochemistry & Molecular Biology | 147 | 23% | 0% | 62 |
| 4 | Biology | 122 | 7% | 0% | 18 |
| 5 | Cell Biology | 73 | 10% | 0% | 28 |
| 6 | Biophysics | 56 | 6% | 0% | 17 |
| 7 | Medicine, Research & Experimental | 51 | 6% | 0% | 17 |
| 8 | Nuclear Science & Technology | 20 | 3% | 0% | 9 |
| 9 | Pharmacology & Pharmacy | 17 | 7% | 0% | 20 |
| 10 | Endocrinology & Metabolism | 14 | 4% | 0% | 11 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CELL BIOL R 124 | 336786 | 1% | 100% | 3 |
| 2 | ADV PROTEOMICS | 112262 | 0% | 100% | 1 |
| 3 | CELL DIFFERENTIATIONAND OPTOSISMINIST | 112262 | 0% | 100% | 1 |
| 4 | DG DRDO | 112262 | 0% | 100% | 1 |
| 5 | EARCHES IMMUNOL | 112262 | 0% | 100% | 1 |
| 6 | HOLDEN COMPREHENS CANC MED S BI80 | 112262 | 0% | 100% | 1 |
| 7 | IRC E7050 | 112262 | 0% | 100% | 1 |
| 8 | KYSHU UNIV MED ABORAT STN 2 | 112262 | 0% | 100% | 1 |
| 9 | MILLER MED SYLVESTER CANC | 112262 | 0% | 100% | 1 |
| 10 | MOL CELL BIOL ANAT | 112262 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ACTA RADIOLOGICA ONCOLOGY | 20325 | 3% | 2% | 9 |
| 2 | JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 7001 | 4% | 1% | 10 |
| 3 | CANCER BIOLOGY & THERAPY | 2551 | 3% | 0% | 8 |
| 4 | CLINICS IN ONCOLOGY | 2116 | 0% | 2% | 1 |
| 5 | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | 1788 | 3% | 0% | 9 |
| 6 | MOLECULAR CANCER THERAPEUTICS | 1343 | 3% | 0% | 7 |
| 7 | CENTRAL EUROPEAN JOURNAL OF BIOLOGY | 1293 | 1% | 0% | 3 |
| 8 | INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS | 1088 | 2% | 0% | 5 |
| 9 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 921 | 4% | 0% | 12 |
| 10 | CANCER CLINICAL TRIALS | 875 | 0% | 1% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 2 DEOXY D GLUCOSE | 802093 | 19% | 14% | 51 | Search 2+DEOXY+D+GLUCOSE | Search 2+DEOXY+D+GLUCOSE |
| 2 | METABOLIC OXIDATIVE STRESS | 144334 | 1% | 43% | 3 | Search METABOLIC+OXIDATIVE+STRESS | Search METABOLIC+OXIDATIVE+STRESS |
| 3 | 6 AMINONICOTINAMIDE | 127915 | 3% | 16% | 7 | Search 6+AMINONICOTINAMIDE | Search 6+AMINONICOTINAMIDE |
| 4 | 2 DEM D GLUCOSE | 112262 | 0% | 100% | 1 | Search 2+DEM+D+GLUCOSE | Search 2+DEM+D+GLUCOSE |
| 5 | 2 DEOXY D GLUCOSE P53 | 112262 | 0% | 100% | 1 | Search 2+DEOXY+D+GLUCOSE+P53 | Search 2+DEOXY+D+GLUCOSE+P53 |
| 6 | 2 METHOXY ANTIMYCIN A | 112262 | 0% | 100% | 1 | Search 2+METHOXY+ANTIMYCIN+A | Search 2+METHOXY+ANTIMYCIN+A |
| 7 | BAX BAK INDEPENDENT | 112262 | 0% | 100% | 1 | Search BAX+BAK+INDEPENDENT | Search BAX+BAK+INDEPENDENT |
| 8 | CAMPTODIECIN | 112262 | 0% | 100% | 1 | Search CAMPTODIECIN | Search CAMPTODIECIN |
| 9 | CANCER VS NORMAL CELLS | 112262 | 0% | 100% | 1 | Search CANCER+VS+NORMAL+CELLS | Search CANCER+VS+NORMAL+CELLS |
| 10 | GBM DIFFERENTIATION | 112262 | 0% | 100% | 1 | Search GBM+DIFFERENTIATION | Search GBM+DIFFERENTIATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | DWARAKANATH, BS , (2009) CYTOTOXICITY,RADIOSENSITIZATION, AND CHEMOSENSITIZATION OF TUMOR CELLS BY 2-DEOXY-D-GLUCOSE IN VITRO.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 5. ISSUE . P. 27 -31 | 23 | 70% | 17 |
| 2 | ZHANG, DS , LI, J , WANG, FZ , HU, J , WANG, SW , SUN, YM , (2014) 2-DEOXY-D-GLUCOSE TARGETING OF GLUCOSE METABOLISM IN CANCER CELLS AS A POTENTIAL THERAPY.CANCER LETTERS. VOL. 355. ISSUE 2. P. 176 -183 | 32 | 34% | 34 |
| 3 | DWARAKANATH, BS , SINGH, D , BANERJI, AK , SARIN, R , VENKATARAMANA, NK , JALALI, R , VISHWANATH, PN , MOHANTI, BK , TRIPATHI, RP , KALIA, VK , ET AL (2009) CLINICAL STUDIES FOR IMPROVING RADIOTHERAPY WITH 2-DEOXY-D-GLUCOSE: PRESENT STATUS AND FUTURE PROSPECTS.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 5. ISSUE . P. 21 -26 | 17 | 77% | 53 |
| 4 | GUPTA, S , FAROOQUE, A , ADHIKARI, JS , SINGH, S , DWARAKANATH, BS , (2009) ENHANCEMENT OF RADIATION AND CHEMOTHERAPEUTIC DRUG RESPONSES BY 2-DEOXY-D-GLUCOSE IN ANIMAL TUMORS.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 5. ISSUE . P. 16 -20 | 22 | 58% | 12 |
| 5 | XI, HB , KURTOGLU, M , LAMPIDIS, TJ , (2014) THE WONDERS OF 2-DEOXY-D-GLUCOSE.IUBMB LIFE. VOL. 66. ISSUE 2. P. 110-121 | 28 | 34% | 14 |
| 6 | FAROOQUE, A , AFRIN, F , ADHIKARI, JS , DWARAKANATH, BS , (2009) PROTECTION OF NORMAL CELLS AND TISSUES DURING RADIO- AND CHEMOSENSITIZATION OF TUMORS BY 2-DEOXY-D-GLUCOSE.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 5. ISSUE . P. 32 -35 | 16 | 70% | 4 |
| 7 | ZHANG, FJ , AFT, RL , (2009) CHEMOSENSITIZING AND CYTOTOXIC EFFECTS OF 2-DEOXY-D-GLUCOSE ON BREAST CANCER CELLS.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 5. ISSUE . P. 41 -43 | 10 | 100% | 10 |
| 8 | VIBHUTI, A , MURALIDHAR, K , DWARAKANATH, BS , (2013) DIFFERENTIAL CYTOTOXICITY OF THE GLYCOLYTIC INHIBITOR 2-DEOXY-D-GLUCOSE IN ISOGENIC CELL LINES VARYING IN THEIR P53 STATUS.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 9. ISSUE 4. P. 686-692 | 16 | 50% | 2 |
| 9 | VARSHNEY, R , GUPTA, S , DWARAKANATH, BS , (2004) RADIOSENSITIZATION OF MURINE EHRLICH ASCITES TUMOR BY A COMBINATION OF 2-DEOXY-D-GLUCOSE AND 6-AMINONICOTINAMIDE.TECHNOLOGY IN CANCER RESEARCH & TREATMENT. VOL. 3. ISSUE 6. P. 659-663 | 14 | 70% | 12 |
| 10 | DJUZENOVA, CS , KRASNYANSKA, J , KIESEL, M , STINGL, L , ZIMMERMANN, U , FLENTJE, M , SUKHORUKOV, VL , (2009) INTRACELLULAR DELIVERY OF 2-DEOXY-D-GLUCOSE INTO TUMOR CELLS BY LONG-TERM CULTIVATION AND THROUGH SWELLING-ACTIVATED PATHWAYS: IMPLICATIONS FOR RADIATION TREATMENT.MOLECULAR MEDICINE REPORTS. VOL. 2. ISSUE 4. P. 633-640 | 16 | 53% | 1 |
Classes with closest relation at Level 1 |